We previously demonstrated that insulin infusion altered metabolite concentrations in cerebral tissues assessed with proton magnetic resonance spectroscopy ( 1 H-MRS) in young subjects with high insulin sensitivity, but not in those with low insulin sensitivity. Fat overload is an important factor leading to insulin resistance.
R ecent data indicate that cognitive impairment and neurodegenerative diseases are closely associated with insulin resistance-related disorders such as obesity, metabolic syndrome, and type 2 diabetes (1, 2). Deficits in learning, memory, and executive function have been reported in healthy overweight and obese humans compared with normal weight individuals (1) . Elevated body mass index (BMI) has been identified as an independent risk factor for Alzheimer disease and vascular dementia (3) . The incidence of dementia, including Alzheimer disease, was higher in people with type 2 diabetes (2). Furthermore, cognitive decline was increased in patients with prediabetes and metabolic syndrome (2) .
Abnormalities of brain morphology on MRI, such as cortical and hippocampal atrophy, were observed in patients with obesity (4) and those with type 2 diabetes (5). Furthermore, studies using proton magnetic resonance spectroscopy ( 1 H-MRS) demonstrated metabolic alterations in cerebral tissues in patients with obesity, impaired glucose tolerance, and type 2 diabetes (6) (7) (8) .
1 H-MRS is a diagnostic method that allows quantification of changes in neurometabolites in vivo and provides information on neuronal viability and cellular energetic and membrane status (9) . N-acetylaspartate (NAA) is a neuronal amino acid used as a marker of neuronal viability. A reduction of NAA reflects neuronal loss and disturbances in neuronal energetics (9) . The choline (Cho) peak in 1 H-MRS includes Cho-containing compounds, which are involved in cell membrane breakdown and synthesis, and may correspond to glial cell proliferation (9) . Myo-inositol (mI) is considered a marker of glial cell number and an osmoregulator (9) . The spectral peaks of glutamate, glutamine, and g-aminobutyric acid (GABA) are grouped together as Glx (9) . Changes in these metabolites could reflect the glutamate/GABA-glutamine cycle. The creatine (Cr) signal refers to Cr-containing metabolites involved in cell bioenergetics. Cr levels tend to remain relatively unchanged except with trauma, a stroke, a tumor, and hyperglycemic conditions. Therefore, Cr is used as a putative internal standard against which other metabolites can be compared (9) . Water peak is also used as an internal reference, with the assumption that the concentration of water does not vary substantially between regions (9). Higher BMI was related to lower concentrations of NAA in the frontal lobe in a healthy middle-aged cohort (6) . A decreased frontal cortical NAA/Cr ratio was observed in patients with type 2 diabetes (8). Lower regional NAA level was associated with higher fasting insulin levels and insulin resistance (8) . Of note, a decrease in the NAA level in cortical and limbic structures was observed in patients with neurodegenerative disorders, such as Alzheimer disease (9) . We previously demonstrated that insulin infusion altered metabolite levels in cerebral tissues assessed with 1 H-MRS in young subjects with high insulin sensitivity, but not in those with low insulin sensitivity (10) . The effects of a high-fat diet (HFD) on brain structure and function are unclear. Saturated and unsaturated fatty acids could pass across the blood-brain barrier. The brain is a lipid-rich environment with many different fatty acids and with cholesterol playing important roles in membrane structure, myelination, and signaling. Fatty acids are used only poorly as fuel in the brain (11) .
An HFD is a leading cause of obesity and related metabolic disorders. Human epidemiological studies indicate that an HFD is associated with worse performance on a cognitive task and increased risk for Alzheimer disease (12) . Many experimental studies have shown that an HFD induces changes in brain tissues and disrupts cognition (13) . It has been demonstrated that an HFD impairs neurogenesis and synaptic plasticity through oxidative stress (14) . Mice fed an HFD demonstrated cognitive impairment and an increase in brain markers of oxidative stress and inflammation (14, 15) . Vascular changes in the cerebral cortex were also observed in hamsters fed an HFD (16) . Some studies indicate that an HFD could have a negative influence on cognitive function through impairment of insulin signaling. An HFD is a source of free fatty acids (FFAs), which induce insulin resistance (17) . Research data show that insulin signaling is crucial for cognition, particularly optimal hippocampal function (18) . Impaired brain insulin signaling was found in Alzheimer disease (19) .
The effects of an HFD on the central nervous system are not well understood. It is unclear whether an HFD influences cognition per se or is related more to HFD-induced obesity and metabolic disturbances. The real mechanism linking an HFD with cognition also remains elusive. Dynamic studies assessing the influence of FFAs on brain structure and function could provide more information.
Therefore, the purpose of the current study was to examine the short-term effect of elevated circulating FFA levels on metabolites in cerebral tissues as assessed with 1 H-MRS.
Subjects and Methods

Study group
The study group comprised 10 young (age between 20 and 30 years), healthy male subjects. All study participants were nonsmokers, had no serious disease or obesity, had normal fasting glucose levels, and were not taking any drugs. Subjects were excluded if they had any inflammatory disease within the previous 3 months. Participants underwent a clinical examination and appropriate laboratory tests. All analyses were performed after an overnight fast. The study protocol was approved by the local ethics committee of the Medical University of Bialystok. Written informed consent was obtained from all volunteers before their participation in the study.
Anthropometric measurements
BMI was calculated as weight in kilograms divided by the square of height in meters. The waist was measured at the smallest circumference between the rib cage and the iliac crest, with the subject in the standing position. Percentage of body fat was assessed by bioelectric impedance analysis using the TBF-511 Body Fat Analyzer (Tanita Corp., Tokyo, Japan).
Study protocol
All participants underwent two studies. Brain structural MRI and 1 H-MRS were performed at basal state and after a 4-hour Intralipid (Fresenius Kabi, Uppsala, Sweden)/heparin or saline infusion, administered in random order within a 1-week interval. Intralipid (Fresenius Kabi) was given at 0.013 mL/kg per minute, and heparin was given at 0.2 U/kg per minute. Saline was infused at the same rate as the Intralipid (Fresenius Kabi) infusion. The infusions were maintained at the same rate during the second brain structural MRI and 1 H-MRS studies.
MRI and 1 H-MRS
Brain structural MRI and 1 H-MRS examinations were performed on a 1.5T scanner (Picker Eclipse; Picker International Inc., Highlands Heights, OH), as previously described (19) . The MRI scan served to exclude any morphological brain abnormalities and to position the voxels (2 3 2 3 2 cm 3 ) for magnetic resonance spectroscopy (MRS). The order of acquisition was as follows: left frontal lobe, left temporal lobe, and left hippocampus. Each MRI scan before each MRS lasted ;3 minutes (;9 minutes total). Each MRS lasted ;8 minutes (;24 minutes total). The total magnetic resonance session lasted 30 to 40 minutes. Metabolites/Cr ratios were analyzed, and metabolites/nonsuppressed H 2 O signal ratios were calculated according to the following formula: metabolite area 3 1000/nonsuppressed water area. The following peaks were assessed: NAA at 2.01 ppm and Cr at 3.03 ppm, Cho at 3.22 ppm, Glx complex in the area from 2.11 to 2.45 ppm, and mI at 3.56 ppm (19) . The spectra were quantified with line fitting.
Laboratory analyses
Plasma glucose level was measured immediately by the enzymatic method using a glucose analyzer (YSI 2300 STAT PLUS; YSI Life Sciences, Yellow Springs, OH). Before estimation of insulin and FFAs, serum samples were kept frozen at 2280°C. Serum insulin level was measured with the monoclonal immunoradiometric assay (DIAsource ImmunoAssays SA, Nivelles, Belgium), with the sensitivity of 1 mIU/mL and with intra-assay and interassay coefficients of variation below 2.2% and 6.5%, respectively. Serum FFAs were assayed using a commercially available kit (Wako Chemicals, Richmond, VA). Serum lipid levels were assessed with colorimetric assays using the Cobas c111 autoanalyzer (Roche Diagnostics, Mannheim, Germany).
Statistical analysis
Statistical analyses were performed with STATISTICA 12.5 (StatSoft, Krakow, Poland). All data are presented as mean 6 SD. Differences in serum FFA concentrations during the Intralipid (Fresenius Kabi)/heparin or saline infusions were assessed with repeated-measures ANOVA with the post hoc Scheffe test. Differences in neurometabolites before and after Intralipid/heparin or saline infusions were analyzed with the paired Student t test without correction for multiple comparisons. Differences between the respective time points of the two experiments were analyzed with the unpaired Student t test. The level of significance was accepted at P value lower than 0.05.
Results
Baseline characteristics of the study groups are presented in Table 1 . Baseline plasma glucose, serum insulin, and FFA levels were not different between the two experiments. Intralipid (Fresenius Kabi)/heparin infusion resulted in a significant increase in serum FFA concentration from 30 minutes until the end of the study (F = 39.16, df = 6; P , 0.0001; post hoc Scheffe test, all P , 0.0001) (Fig. 1A) . Serum FFA levels remained unchanged during the saline infusion (F = 0.88, df = 6; P = 0.52) (Fig. 1B) and were significantly lower than respective values during the Intralipid (Fresenius Kabi)/ heparin infusion from 30 minutes until the end of the study (all P , 0.0001).
Typical spectra from the left frontal lobe ( Fig. 2A) , left temporal lobe (Fig. 2B) , and left hippocampus (Fig. 2C) were analyzed. Baseline NAA, Cho, mI, and Glx values in the frontal and temporal regions and in the hippocampus were not different between the two experiments after correction for both Cr and H 2 O (Figs. 3 and 4) . We observed significant changes in brain neurometabolites in response to the Intralipid (Fresenius Kabi)/heparin infusion: an increase in frontal mI/Cr (P = 0.041) and mI/ H 2 O (P = 0.037), a decrease in frontal and hippocampal Glx/Cr (P = 0.018 and P = 0.015, respectively) and Glx/ H 2 O (P = 0.03 and P = 0.067, nonsignificant, respectively), and a decrease in hippocampal NAA/Cr (P = 0.007) and NAA/H 2 O (P = 0.019). No changes in neurometabolites were observed in the temporal region. No correlations between changes in circulating FFA levels and brain neurometabolites were found. Ratios of neurometabolites did not change during the saline infusion (Figs. 3 and 4) .
Discussion
We discovered that elevation of circulating FFA levels obtained during Intralipid (Fresenius Kabi)/heparin infusion resulted in significant changes in brain neurochemistry assessed with 1 H-MRS in young healthy men. In particular, we observed a decrease in frontal and hippocampal Glx/Cr and Glx/H 2 O, a decrease in hippocampal (20) . Glutamine is synthesized from glutamate by glutamine synthetase in glia and is converted back to glutamate by glutaminase in neurons, completing the glutamate-glutamine cycle (20) . Glutamate and glutamine are most abundant in neurons and astrocytes, respectively. Glutamate is also the precursor of GABA, the major inhibitory neurotransmitter. A balance of glutamatergic and GABAergic transmission is required to maintain proper brain function (20) . In hippocampal and cortical circuits, glutamate transmission accounts for learning and memory processes (20) . A study in mice indicated that an HFD altered glutamate metabolism in the hippocampus (21) . Concomitant impairment in synaptic transmission and plasticity within the hippocampus was also observed. The authors suggested that an HFD triggers significant changes in glutamate transmission in the hippocampus, which may account for cognitive deficits (21) . In an 1 H-MRS study, a lower glutamate/glutamine ratio was observed in the hippocampus of high fat-fed rats, suggesting a shift in the balance of the glutamateglutamine cycle (22) . An HFD may disrupt GABA metabolism, as glutamate is its precursor. Decreased concentration of GABA was observed in the frontal cortex and hippocampus of rats fed an HFD (23) . On the other hand, no changes in GABA levels were found in another study in mice after an HFD (24) .
Our data indicate that elevated circulating FFA level influenced the glutamate-glutamine cycle and/or GABA metabolism. It may be a sign of altered neuronal metabolism and glutamatergic and GABAergic neuotransmission. Separate determination of glutamate, glutamine, and GABA could be more informative.
However, glutamate is the most abundant excitatory amino acid transmitter in the brain (25) . As many as 90% of the neurons in the brain use glutamate as their neurotransmitter, and approximately 80% to 90% of the synapses in the brain are glutamatergic (25) . Glutamatergic activity may account for as much as 80% of the energy expenditure of the brain (25) . Furthermore, previous data indicate that glutamate is the main metabolite in the Glx spectrum (26) . We speculate that the (20) . The decreased Glx ratios may be due to impaired brain energy metabolism during a lipid infusion. Of note, TCA cycle activity and glutamate-glutamine cycling were reduced in various parts of the brain in animal models of obesity, prediabetic state, and type 2 diabetes (27) . After adjustment for age, greater BMI was related to lower glutamate levels in the anterior cingulate cortex in healthy elderly individuals (8) . Of note, nuclear MRS showed decreased glutamate neurotransmission activity and TCA cycling rate in patients with Alzheimer disease (28) . It could be responsible for the cognitive impairment that is characteristic of this disease.
FFA elevation could influence glutamatergic activity by affecting mitochondrial energetic processes in the brain. Emerging evidence has suggested that insulin signaling plays a role in glutamatergic and GABAergic transmission (19) Furthermore, in our previous study, we observed that a 4-hour insulin infusion increased Glx/Cr and Glx/H 2 O in the cerebral tissues of young healthy men with high insulin sensitivity. This effect did not occur in men with low insulin sensitivity (11) . Insulin-stimulated Glx was also related positively to insulin sensitivity (11) . Many studies have indicated that FFAs contribute to insulin resistance. When the protocol with Intralipid (Fresenius Kabi)/heparin infusion used in the current study was combined with insulin sensitivity measurement with the hyperinsulinemic-euglycemic clamp, an ;40% decrease in glucose infusion rate was observed after 4 to 6 hours of the study (29) . Our data may indicate that FFA elevation by induction of insulin resistance affected energetic processes and glutamate-glutamine cycle activity and reduced glutamatergic neurotransmission.
In our study, an Intralipid (Fresenius Kabi)/heparin infusion resulted in decreases in hippocampal NAA/Cr and NAA/H 2 O. Because NAA is a marker of neuronal density, functionality, and metabolism, our data suggest that an acute FFA elevation could impair neuronal functionality and metabolism. We speculate that chronic exposure to excess fat may result in the development of obesity and metabolic diseases, as well as lead to neuronal dysfunction and damage and, consequently, to poorer cognition. It has been shown that higher BMI is related to lower concentrations of NAA in the frontal gray matter in healthy middle-aged people (7). Brain atrophy and a lower concentration of NAA are risk factors for cognitive decline and dementia in elderly adults (30) . Decreased frontal cortical NAA/Cr was also observed in patients with type 2 diabetes (9). In our previous study, we found that NAA/Cr and NAA/H 2 O in the frontal cortex increased in insulin-stimulated conditions in subjects with high insulin sensitivity but not in those with low insulin sensitivity (11) . We also observed a significant correlation between insulin sensitivity and frontal NAA. Sahin et al. (8) showed that lower frontal NAA level was associated with higher insulin resistance in patients with type 2 diabetes. The data described previously indicate that insulin resistance may be one of the mechanisms linking elevation in FFAs with abnormalities in cerebral metabolism, function, and structure.
In the current study, we observed increases in frontal mI/Cr and mI/H 2 O in response to the Intralipid (Fresenius Kabi)/heparin infusion. The lower concentration of mI was observed in the hippocampus of rats fed an HFD (22) . mI is involved in the metabolism of cell membrane inositol phospholipids, which is fundamental for cellular signal transduction. It is a substrate of the components of the phosphoinositide pathways (10) . The pathways of inositol lipid metabolism associated with phosphatidylinositol 3-kinase and production of the phosphorylated derivatives of phosphoinositide can be activated by insulin (19) . Insulin resistance induced by FFA elevation may decrease concentrations of the inositol metabolites in these pathways and could increase mI levels in the brain. This agrees with our previous results, in which we observed a decrease in cerebral mI level during insulin infusion in young men with high insulin sensitivity (11) . An increase in the mI/Cr ratio in the frontal cortex was observed in subjects with type 2 diabetic compared with controls. These findings also suggest a role of increased insulin resistance in the observed changes. Because mI is found at high concentrations in astrocytes (26), we speculate that a chronic insulin resistance state could result in changes in the astroglial population. Increases in mI levels have been reported in the brain of patients with Alzheimer disease and have been correlated with decline in cognitive performance (31) . It has been suggested that mI is a marker of glial proliferation in this disease (31) .
Our data confirm that acute FFA elevation influences brain metabolism. Lipid-induced insulin resistance may be an important potential mechanism linking an HFD with structural and functional abnormalities in the brain. However, other potential mechanisms, such as oxidative stress or a decrease in brain-derived neurotrophic factor (BDNF) in cerebral tissues, could also play a role in these processes. Park et al. (14) discovered that an HFD impaired neurogenesis and synaptic plasticity through oxidative stress followed by the accumulation of peroxidized lipids and decreased the level of BDNF in the hippocampus. We discovered that raising FFA levels decreased circulating BDNF concentration (29) .
On the other hand, there are studies indicating a positive effect of an HFD on brain function. An HFD that led to mild ketonemia improved brain function in elderly women (32) . Elevation of circulating ketone concentrations by consumption of high-fat, low-carbohydrate diets has been used for the treatment of drug-resistant epilepsy and Parkinson disease (33, 34) . A long-term HFD in rats resulted in mild ketonemia, better memory, and larger hippocampal volumes, as well as higher hippocampal NAA and Glu concentrations (24) . The level of circulating FFAs was not measured in this study. Murray et al. (35) discovered that a diet containing a novel ketone ester as 30% of calories improved cognitive function in rats. Of note, this diet contained only 4% of calories from fat. It has been shown that after 14 days, supplementation with the ketone ester lowered blood glucose and insulin levels, which indicates an improvement in insulin sensitivity (36) . This is in contrast to hyperlipidemia produced by the ketogenic diet. However, MRS studies in children with type 1 diabetes and diabetic ketoacidosis showed metabolic changes consistent with cerebral injury (37) . In a study of Glaser et al. (38) , brain NAA/Cr ratios were diminished in diabetic ketoacidosis, which is associated with excessive elevation of blood ketone levels and hyperglycemia. In another study, no significant effect of ketosis on cerebral NAA/Cr ratios was observed (39) . As the most energy-efficient fuel, ketones may be beneficial for the brain. However, it is difficult to raise circulating ketone levels with a diet without concurrent elevation of blood lipid levels, which could abolish the benefits of the ketones.
The previously described data indicate that the effect of an HFD on the brain may depend on the duration of the diet, the percentage of calories from fat, the amount of concomitant nutrients and blood ketone levels induced by this diet, and the development of HFD-related metabolic disturbances, such as alterations in blood lipids, insulin resistance, oxidative stress, and inflammation. Further studies examining the association between an HFD and predisposition to neurodegenerative disorders are warranted.
Limitations of our study are a small sample size and inclusion of only male subjects. However, even with the small sample size, we were able to demonstrate significant effects of FFA elevation. Further studies in different groups of subjects are required to confirm the generalizability of our findings.
The present data indicate that elevation in acute circulating FFA level influences cerebral metabolites in healthy humans and that lipid-induced insulin resistance may be one of the mechanisms responsible for these effects.
